NCT06228586View on ClinicalTrials.gov

Study on a MenACYW Conjugate Vaccine Administered as a Single Dose in Participants Aged 12 Months and Older in Vietnam

PHASE3CompletedINTERVENTIONAL
Enrollment

447

Participants

Timeline

Start Date

January 18, 2024

Primary Completion Date

March 31, 2024

Study Completion Date

March 31, 2024

Conditions
Meningococcal InfectionHealthy Volunteers
Interventions
BIOLOGICAL

Meningococcal Polysaccharide (Serogroups A, C, W, and Y) Tetanus Toxoid Conjugate Vaccine

Pharmaceutical form:Liquid solution-Route of administration:Intramuscular injection

Trial Locations (4)

70000

Investigational Site Number : 7040003, Thái Bình

Investigational Site Number : 7040004, Thái Bình

410000

Investigational Site Number : 7040002, Thái Bình

Unknown

Investigational Site Number : 7040001, Hanoi

All Listed Sponsors
lead

Sanofi Pasteur, a Sanofi Company

INDUSTRY

NCT06228586 - Study on a MenACYW Conjugate Vaccine Administered as a Single Dose in Participants Aged 12 Months and Older in Vietnam | Biotech Hunter | Biotech Hunter